Our results in cells expressing MDR1 suggested that this pump can export doxorubicin, but not idarubicin, supporting the hypothesis that MDR1 upregulation in blasts from NR patients is involved in the mechanisms of chemoresistance developed by AML cells to overcome response to treatment. Here, ABCB1 is linked to acute myeloid leukemia.